Figure 3.

Median PSA levels (ng/ml +/- 1 standard deviation) for patients who did not receive ADT and who have a minimum follow-up of 12 month in the (A) 35 Gy dose level and (B) 36.25 Gy dose level.

Katz et al. BMC Urology 2010 10:1   doi:10.1186/1471-2490-10-1
Download authors' original image